ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
14.74
-0.39 (-2.58%)
At close: Mar 27, 2026, 4:00 PM EDT
15.38
+0.64 (4.34%)
After-hours: Mar 27, 2026, 7:39 PM EDT
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $132.18 million as of March 27, 2026. Its market cap has increased by 429.34% in one year.
Market Cap
132.18M
Enterprise Value
126.03M
1-Year Change
429.34%
Ranking
Category
Stock Price
$14.74
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $132.18M, an increase of 505.74%. That is a compound annual growth rate of 13.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 135.68M | 823.60% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunic | 163.08M |
| Molecular Partners AG | 162.74M |
| Cartesian Therapeutics | 160.91M |
| Precision BioSciences | 158.25M |
| ProQR Therapeutics | 156.99M |
| Acumen Pharmaceuticals | 156.89M |
| Achieve Life Sciences | 154.40M |
| Evaxion | 153.25M |